# ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery

> **NCT01579201** · PHASE4 · UNKNOWN · sponsor: **Maisonneuve-Rosemont Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Postpartum Hemorrhage
- Uterine Atony

## Interventions

- **DRUG:** Carbetocin

## Key facts

- **NCT ID:** NCT01579201
- **Lead sponsor:** Maisonneuve-Rosemont Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01579201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01579201, "ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01579201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*